ArticleScientific reports2025
Machine learning for risk prediction of acute kidney injury in patients with diabetes mellitus combined with heart failure during hospitalization.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence in chronic kidney disease: Early detection, risk prediction, and personalized treatment strategies.World journal of nephrology · 2026Review
- International Delphi consensus on acute kidney injury: Foundations for AI-driven digital twin development in critical care nephrology.PloS one · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to develop a machine learning (ML) model for predicting the risk of acute kidney injury (AKI) in diabetic patients with heart failure (HF) during hospitalization. Using data from 1,457 patients in the MIMIC-IV database, the study identified twenty independent risk factors for AKI through LASSO regression and logistic regression. Six ML algorithms were evaluated, including LightGBM, random forest, and neural networks. The LightGBM model demonstrated superior performance with the highest prediction accuracy, with AUC values of 0.973 and 0.804 in the training and validation sets, respectively. The Shapley additive explanations algorithm was used to visualize the model and identify the most relevant features for AKI risk. Clinical impact curves further confirmed the strong discriminatory ability and generalizability of the LightGBM model. This study highlights the potential of ML models, particularly LightGBM, to effectively predict AKI risk in diabetic patients with HF, enabling early identification of high-risk patients and timely interventions to improve prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.